Skip to main content

Menopausal Hormone Therapy (MHT) patch shortages May 2024

Australia 

Patch Shortages

There are a number of MHTs that are currently unavailable. Please note that the TGA has approved some unregistered products under Section 19A and some substitute doses are currently in supply in Australia.

Pharmacists are encouraged to contact suppliers Medsurge Healthcare Pty Ltd on 1300 788 261 for orders of Estramon and Sandoz on 1800 726 369 for orders of Estradiol Transdermal System.

Oestradiol patches

 

Expected supply due

Alternative supply under Section 19A

Dose

Estradot

Estraderm

Estramon

Estradiol Transdermal System

25 mcg

15 Jun 2024

Available

Available

 

37.5 mcg

20 Sep 2024

 

Available

Available

50 mcg

15 Jun 2024

1 Aug 2024

Available

 Available

75 mcg

15 Jun 2024

1 Aug 2024

Available

Available

100 mcg

15 Jul 2024

1 Aug 2024

Available

Available

Combined patches

Dose

Estalis Sequi

Estalis Conti

50/140

17 June 2024

8 Jun 2024

50/250

15 Jul 2024

3 Aug 2024

All doses of Climara have been deleted from the market and there will be a reduction in supply until supply is exhausted.

The AMS Guide to MHT Doses (Australia only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in Australia.

Read more: Menopausal Hormone Therapy (MHT) patch shortages May 2024

Menopause Survey for Women

AMS Survey page 
 
Would you like to help the #EmbraceTheChange campaign for #perimenopause and #menopause?
You can have a voice about:
+ Impacts of perimenopause and/or menopause on your quality of life
+ Your experiences going to a doctor
+ What you think needs to change
 
This survey is targeted at peri- or post-menopausal Australian women* to inform the Australasian Menopause Society's advocacy campaign.
*Please refer to the AMS Gender Language Policy
 
You may access the survey at Menopause Survey for Women or use the QR COde shown.

QR code for survey

Read more: Menopause Survey for Women